AU3673500A - Fine particles targeting cells and process for producing the same - Google Patents
Fine particles targeting cells and process for producing the sameInfo
- Publication number
- AU3673500A AU3673500A AU36735/00A AU3673500A AU3673500A AU 3673500 A AU3673500 A AU 3673500A AU 36735/00 A AU36735/00 A AU 36735/00A AU 3673500 A AU3673500 A AU 3673500A AU 3673500 A AU3673500 A AU 3673500A
- Authority
- AU
- Australia
- Prior art keywords
- producing
- same
- fine particles
- targeting cells
- particles targeting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
- A61K47/6913—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome the liposome being modified on its surface by an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10102099 | 1999-04-08 | ||
JP11/101020 | 1999-04-08 | ||
PCT/JP2000/002272 WO2000061114A1 (en) | 1999-04-08 | 2000-04-07 | Fine particles targeting cells and process for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3673500A true AU3673500A (en) | 2000-11-14 |
Family
ID=14289532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU36735/00A Abandoned AU3673500A (en) | 1999-04-08 | 2000-04-07 | Fine particles targeting cells and process for producing the same |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3673500A (en) |
WO (1) | WO2000061114A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9915074D0 (en) * | 1999-06-28 | 1999-08-25 | Cortecs Plc | Ligand-binding composition |
JP2006089471A (en) * | 2004-08-26 | 2006-04-06 | National Institute Of Advanced Industrial & Technology | Use of antimortalin 2 antibody and functional nucleic acid in treatment of cancer |
CA2609817A1 (en) * | 2005-05-26 | 2006-11-30 | Mebiopharm Co., Ltd. | Gene transfer method |
JP4881327B2 (en) * | 2006-01-31 | 2012-02-22 | 大鵬薬品工業株式会社 | Liposome preparation of antitumor active substance |
EP3908325A1 (en) * | 2019-01-07 | 2021-11-17 | Ucl Business Ltd | Polymersomes functionalised with multiple ligands |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2072249C (en) * | 1991-06-28 | 2003-06-17 | Saiko Hosokawa | Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
JPH09110722A (en) * | 1995-10-20 | 1997-04-28 | Toray Ind Inc | Immunoliposome for transducing tumorous cell of antitumor active substance and its preparation |
-
2000
- 2000-04-07 AU AU36735/00A patent/AU3673500A/en not_active Abandoned
- 2000-04-07 WO PCT/JP2000/002272 patent/WO2000061114A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000061114A1 (en) | 2000-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8997098A (en) | Propylene copolymer and process for the production thereof | |
AU4467801A (en) | Chlamydospores and process for producing the same | |
AU2855499A (en) | Oxirane derivatives and process for producing the same | |
AU1351299A (en) | Detergent particles and method for producing the same | |
AU1303801A (en) | Transplant material and process for producing the same | |
AU2003284575A1 (en) | Fine composite particle and process for producing the same | |
AU2000273206A1 (en) | Photocatalyst-bearing material and method of producing the same | |
AU6228699A (en) | Process for producing spherical fine particles containing drug | |
AU6678100A (en) | Process for producing thermoelectric material and thermoelectric material thereof | |
AU1413701A (en) | Porous beads and process for producing the same | |
AU6067200A (en) | Systems and methods for producing and using fine particle materials | |
AU1306601A (en) | Chemically modified supports and process for producing the same | |
AU2144900A (en) | Substantially spherical magneto-plumbite ferrite particles and methods for producing and media employing the same | |
AU1683499A (en) | Bilberry-containing drinks and process for producing the same | |
MXPA01012658A (en) | Methods for coating particles and particles produced thereby. | |
AU7807800A (en) | Filter materials and methods for the production thereof | |
AU3673500A (en) | Fine particles targeting cells and process for producing the same | |
AU5057600A (en) | Component and method for the production thereof | |
AU5625700A (en) | Detergent particles and processes for making them | |
AU7563800A (en) | Marsh-mallow and the marsh-mallow production technique | |
AU2547399A (en) | Pyridone derivatives and process for producing the same | |
AU3193200A (en) | Tablets and process for producing the same | |
AU1734801A (en) | Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyrancompound | |
HUP0105166A3 (en) | Substances wk-5344a and wk-5344b and process for producing the same | |
AU1653200A (en) | Polymer-containing particle and process for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |